MATRIX: Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia
Clinical trial NCT01556685 · COMPLETED
Trial details
- NCT number
- NCT01556685
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2011-10-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.